InvestorsHub Logo
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Re: None

Wednesday, 11/09/2016 8:36:55 AM

Wednesday, November 09, 2016 8:36:55 AM

Post# of 592
Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results

http://investor.eagleus.com/press-release/eagle-pharmaceuticals-inc-reports-third-quarter-2016-results

-- Bendeka achieves market share of 88% --

-- CMS establishes unique J-Code for Bendeka --

-- Positive initial results of Ryanodex in MDMA animal study --

-- Q3 EPS increases to $0.77 per basic and $0.73 per diluted, Total Revenue $37.8 million --
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News